Tradestie Institutional Equity Comparison Engine

CODX vs BMRA โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

CODX Overall Edge

CODX Captures Institutional Edge (2โ€“2 Pillars ยท 5โ€“4 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Co-Diagnostics, Inc. Common Stock (CODX) driven by superior Valuation, Momentum & Technical while BMRA counters with relative strength in Growth & Margin, Options & Structure. Fundamentally, CODX trades at 15.4x Forward P/E with -3415.8% operating margin (+94.6% YoY revenue) versus BMRA at N/M Forward P/E and -125.2% operating margin (-8.3% YoY). In options structure, CODX sits in BREAKDOWN (50th %ile IV; Dealer Gamma Walls on Pro) against BMRA sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner CODX
CODX 15.4x vs BMRA N/M Fwd P/E
Growth & Margin Winner BMRA
Op Margin -3415.8% vs -125.2% ยท YoY +94.6% vs -8.3%
Momentum & Technical Winner CODX
1Y -45.9% vs -46.9% ยท 52W Pos 0% vs 4%
Options & Structure Winner BMRA
BREAKDOWN (50th %ile IV) vs UNCLASSIFIED (N/A IV)
CODX NASDAQ
Co-Diagnostics, Inc. Common Stock
Surgical & Medical Instruments & Apparatus
$0.23
-12.26% 1D
Market Cap $2.3M
1M Return -65.31%
1Y Return -45.9%
Forward P/E 15.4x
Unified AI Score
51.6 / 100 HOLD
Tech 55.0 Fund 54.0 Flow 66.0 Mom 40.0
BMRA NASDAQ
Biomerica Inc
In Vitro & In Vivo Diagnostic Substances
$1.33
-2.32% 1D
Market Cap $6.0M
1M Return -28.19%
1Y Return -46.86%
Forward P/E N/M
Unified AI Score
44.5 / 100 HOLD
Tech 40.0 Fund 47.0 Flow 50.0 Mom 44.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: CODX -45.9% BMRA -46.86% Spread: +7.85 pp (CODX Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period CODX Revenue BMRA Revenue CODX Op. Margin BMRA Op. Margin Margin Edge
FY2019 $0M $10M -2741.6% -46.4% BMRA
FY2020 $70M $10M 55.9% -41.0% CODX
FY2021 $100M $10M 47.1% -104.2% CODX
FY2022 $30M $20M -78.8% -24.0% BMRA
FY2023 $10M $10M -626.9% -135.3% BMRA
FY2024 $0M $10M -1023.7% -117.6% BMRA
FY2025 $0M $10M -8058.8% -96.7% BMRA
FY2026 N/A $0M N/A -119.5% BMRA

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: CODX (5) vs BMRA (4)
Institutional Metric CODX BMRA Criterion Row Winner
Market Capitalization Scale $2.3M $6.0M Larger Scale Tie
Trailing P/E Ratio Valuation 15.4x N/M Lower Multiple CODX
Forward P/E Ratio Valuation 15.4x N/M Lower Multiple CODX
Revenue Growth (YoY) Growth +94.6% -8.3% Higher Growth CODX
Operating Margin (TTM) Profitability -3415.8% -125.2% Higher Margin BMRA
Net Profit Margin Profitability 0.0% -115.5% Higher Margin CODX
Return on Equity (ROE) Capital Efficiency -192.8% -113.8% Higher ROE BMRA
52-Week Range Position Momentum 0% ($0โ€“$14) 4% ($1โ€“$3) Stronger Trend BMRA
Beta / 30D Volatility Risk Regime 2.92ฮฒ ยท 148% Vol 0.67ฮฒ ยท 62% Vol Lower Realized Risk BMRA
Unified Institutional Score Composite Signal 51.6 / 100 (HOLD) 44.5 / 100 (HOLD) Higher Composite CODX

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full CODX vs BMRA Buy Guide
CODX BREAKDOWN
173d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 50th %ile
IV Regime Balanced (25thโ€“60th %ile)
Live CODX Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
BMRA UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live BMRA Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither CODX nor BMRA registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.